Understanding how inflammation destroys insulin-producing cells in diabetes
Biochemical Mechanism of Beta-Cell Destruction
This study is looking at how certain substances in the body can harm the insulin-making cells in people with autoimmune diabetes, with the hope of finding new ways to protect those cells and improve treatments for the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-11060020 on NIH RePORTER |
What this research studies
This research investigates the biochemical mechanisms behind the destruction of insulin-producing beta cells in autoimmune diabetes. It focuses on how inflammatory cytokines, particularly IL-1, affect beta cell function and viability, leading to reduced insulin production. By examining the cellular responses to these cytokines, the study aims to uncover potential therapeutic targets to protect beta cells from damage. Patients may benefit from insights that could lead to new treatments for autoimmune diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with autoimmune diabetes who are experiencing beta cell dysfunction.
Not a fit: Patients with type 2 diabetes or those whose diabetes is not autoimmune in nature may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that protect insulin-producing cells and improve diabetes management.
How similar studies have performed: Previous research has shown promising results in understanding the role of cytokines in beta cell destruction, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Corbett, John a — Medical College of Wisconsin
- Study coordinator: Corbett, John a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.